Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Gorman Kevin Charles received 14,343 Neurocrine Biosciences, Inc. shares as an award (Form 4)
Traded Sep 11, 2026 · Filed Sep 15, 2026
On Sep 11, 2026, Gorman Kevin Charles (Director) received 14,343 Neurocrine Biosciences, Inc. shares as an award, leaving 517,797 shares. Filed Sep 15, 2026 (Form 4).
- Awarded
- 14,343 shares
- Holding after
- 517,797 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Award | 14,343 | 525,636 | Direct | |
| Sep 11, 2026 | Common Stock | Shares withheld for tax | 7,839 | US$156.22 | 517,797 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Gorman Kevin Charles
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Gorman Kevin Charles · May 21, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026